Axon Enterprise, Inc.

Axon held $14.4 billion in total bookings backlog at year-end FY2025, more than five times its annual revenue, with average contract durations approaching ten years. Annual recurring revenue of $1.35 billion carried net revenue retention above 120%, providing multi-year forward visibility well above typical technology peers.

Axon's portfolio spans TASER weapons, body cameras, fleet cameras, drone detection, and a cloud software suite including evidence management and AI report-writing. All major product lines serve the same public safety and law enforcement end market, limiting true end-market diversification despite the breadth of individual product categories.

Approximately 83% of FY2024 revenue originated in the United States, with international markets at roughly 17% as expansion into Western Europe, Australia, and Japan accelerates. The near-term revenue footprint remains concentrated in a single country, creating sensitivity to U.S. government budget cycles and domestic policy shifts.

The Software and Services segment carries structurally lower incremental costs than Connected Devices hardware, so each additional software seat on an existing agency contract contributes at high incremental margins. Adjusted EBITDA held at 25.5% in FY2025 with management targeting 28% by FY2028, reflecting operating leverage from deepening software penetration across the installed hardware base.

Annual recurring revenue comprised approximately 49% of FY2025 total revenue, delivered through cloud subscriptions for evidence management, records, and AI services that agencies treat as mission-critical infrastructure. Net revenue retention above 120% through FY2021 to FY2025 reflects sustained upsell into existing accounts rather than pure volume acquisition.